Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML
Main Authors: | , , , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-08-01
|
Series: | Blood Advances |
Online Access: | http://www.sciencedirect.com/science/article/pii/S247395292030625X |